Metabolic syndrome and nephrolithiasis: A systematic review and meta-analysis of the scientific evidence

Journal of Nephrology

Volumn 27, Issue 4, 2014, Pages 371-376

  Rendina, Domenico ^a   De Filippo, Gianpaolo ^a   D'Elia, Lanfranco ^a   Strazzullo, Pasquale ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Adult age; Children; Dietary habits; Metabolic syndrome; Nephrolithiasis

Indexed keywords

BODY MASS; DIET; ENVIRONMENT; GENDER; HUMAN; HYPERINSULINEMIA; INSULIN SENSITIVITY; LIPOTOXICITY; META ANALYSIS; METABOLIC SYNDROME X; NEPHROLITHIASIS; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PREVALENCE; REVIEW; SALT INTAKE; SODIUM EXCRETION; SYSTEMATIC REVIEW; URINE PH; AGE; CHEMISTRY; FEEDING BEHAVIOR; METABOLISM;

AGE FACTORS; FOOD HABITS; HUMANS; KIDNEY CALCULI; METABOLIC SYNDROME X; NEPHROLITHIASIS;

EID: 84904458675     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.1007/s40620-014-0085-9     Document Type: Review

References (57)

1. http://www. who. int/topics/cardiovascular_diseases/en/. Accessed November 25, 2013.
2. Reaven GM (1988) Banting lecture: role of insulin resistance in human disease. Diabetes 37: 1595-1607.
3. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications, part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15: 539-553.
4. Balkau B, Charles MA (1999) Comment on the provisional report from the WHO consultation: European Group for the Study of Insulin Resistance. Diabet Med 16: 442-443.
5. National Cholesterol Education Program (2002) NCEP expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel iii): third report of the NCEP expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel iii) final report. Circulation 106: 3143-3421.
6. Einhorn D, Reaven GM, Cobin RH et al (2003) American college of endocrinology position statement on the insulin resistance syndrome. Endocr Pract 9: 237-252.
7. International Diabetes Federation. Worldwide definition of the metabolic syndrome. http://www. idf. org/webdata/docs/IDF_Metasyndrome_definition. pdf. Accessed November 25, 2013.
8. Grundy SM, Cleeman JI, Daniels SR et al (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735-2752.
9. Mottillo S, Filion KB, Genest J et al (2010) The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 56: 1113-1132.
10. Gorbachinsky I, Akpinar H, Assimos DG (2010) Metabolic syndrome and urologic diseases. Rev Urol 12: e157-e180.
11. Thomas G, Sehgal AR, Kashyap SR, Srinivas TR, Kirwan JP, Navaneethan SD (2011) Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol 6: 2364-2373.
12. West B, Luke A, Durazo-Arvizu RA, Cao G, Shoham D, Kramer H (2008) Metabolic syndrome and self-reported history of kidney stones: the national health and nutrition examination survey 1988-1994. Am J Kidney Dis 51: 741-747.
13. Rendina D, Mossetti G, De Filippo G et al (2009) Association between metabolic syndrome and nephrolithiasis in an inpatient population in southern Italy: role of gender, hypertension and abdominal obesity. Nephrol Dial Transplant 24: 900-906.
14. Jeong IG, Kang T, Bang JK et al (2011) Association between metabolic syndrome and the presence of kidney stones in a screened population. Am J Kidney Dis 58: 383-388.
15. Jung HS, Chang IH, Kim KD et al (2011) Possible relationship between metabolic syndrome traits and nephrolithiasis: incidence for 15 years according to gender. Korean J Urol 52: 548-553.
16. Kim YJ, Kim CH, Sung EJ, Kim SR, Shin HC, Jung WJ (2013) Association of nephrolithiasis with metabolic syndrome and its components. Metabolism 62(6): 808-813.
17. D'Elia L, Barba G, Cappuccio FP, Strazzullo P (2011) Potassium intake, stroke, and cardiovascular disease a meta-analysis of prospective studies. J Am Coll Cardiol 57(10): 1210-1219.
18. Dersimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
19. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(557e): 60.
20. Bax L, Yu LM, Ikeda N, Tsuruta H, Moons KG (2006) Development and validation of mix: comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol 6: 50.
21. Weiss R, Dziura J, Burgert TS et al (2004) Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350: 2362-2374.
22. Viggiano D, De Filippo G, Rendina D et al (2009) Screening of metabolic syndrome in obese children: a primary care concern. J Pediatr Gastroenterol Nutr 49: 329-334.
23. De Filippo G, Rendina D, Strazzullo P (2010) Childhood obesity, other cardiovascular risk factors, and premature death. N Engl J Med 362: 1841.
24. Tiwari R, Campfield T, Wittcopp C et al (2012) Metabolic syndrome in obese adolescents is associated with risk for nephrolithiasis. J Pediatr 160: 615-620.
25. Sas JD (2011) An update on the changing epidemiology and metabolic risk factors in pediatric kidney stone disease. Clin J Am Soc Nephrol 6: 2062-2068.
26. Chang IH, Lee YT, Lee DM et al (2011) Metabolic syndrome, urine pH, and time-dependent risk of nephrolithiasis in Korean men without hypertension and diabetes. Urology 78: 753-758.
27. Okamoto M, Kohjimoto Y, Iba A, Saji F, Hara I, Shigematsu T (2010) Calcium oxalate crystal deposition in metabolic syndrome model rat kidneys. Int J Urol 17: 996-1003.
28. Rendina D, De Filippo G, Zampa G, Muscariello R, Mossetti G, Strazzullo P (2011) Characteristic clinical and biochemical profile of recurrent calcium-oxalate nephrolithiasis in patients with metabolic syndrome. Nephrol Dial Transplant 26: 2256-2263.
29. Kohjimoto Y, Sasaki Y, Iguchi M, Matsumura N, Inagaki T, Hara I (2013) Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan. Am J Kidney Dis 61(6): 923-929.
30. Coe FL, Evan A, Worcester E (2005) Kidney stone disease. J Clin Investig 115: 2598-2608.
31. Worcester EM, Coe FL (2010) Clinical practice: calcium kidney stones. N Engl J Med 363: 954-963.
32. Kadlec AO, Greco K, Fridirici ZC, Hart ST, Vellos T, Turk TM (2012) Metabolic syndrome and urinary stone composition: what factors matter most? Urology 80: 805-810.
33. Cho ST, Jung SI, Myung SC, Kim TH (2013) Correlation of metabolic syndrome with urinary stone composition. Int J Urol 20: 208-213.
34. Sakhaee K, Maalouf NM, Sinnott B (2012) Kidney stones 2012: pathogenesis, diagnosis, and management: clinical review. J Clin Endocrinol Metab 97: 1847-1860.
35. Maalouf NM (2011) Metabolic syndrome and the genesis of uric acid stones. J Ren Nutr 21: 128-131.
36. Sakhaee K, Capolongo G, Maalouf NM et al (2012) Metabolic syndrome and the risk of calcium stones. Nephrol Dial Transplant 27: 3201-3209.
37. Ekeruo WO, Tan YH, Young MD et al (2004) Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. J Urol 172: 159-163.
38. Taylor EN, Curhan GC (2006) Body size and 24-hour urine composition. Am J Kidney Dis 48: 905-915.
39. Liu L, Zacchia M, Tian X et al (2010) Acid regulation of NaDC-1 requires a functional endothelin B receptor. Kidney Int 78: 895-904.
40. Hamm LL, Hering-Smith KS (2002) Pathophysiology of hypocitraturic nephrolithiasis. Endocrinol Metab Clin North Am 31: 885-893.
41. Abate N, Chandalia M, Cabo-Chan AV Jr, Moe OW, Sakhaee K (2004) The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int 65: 386-392.
42. Maalouf NM, Cameron MA, Moe OW, Adams-Huet B, Sakhaee K (2007) Low urine pH: a novel feature of the metabolic syndrome. Clin J Am Soc Nephrol 2: 883-888.
43. Li WM, Chou YH, Li CC et al (2009) Association of body mass index and urine pH in patients with urolithiasis. Urol Res 37: 193-196.
44. Sakhaee K, Adams-Huet B, Moe OW, Pak CY (2002) Pathophysiologic basis for normouricosuric uric acid nephrolithiasis. Kidney Int 62: 971-979.
45. Sakhaee K, Maalouf NM (2008) Metabolic syndrome and uric acid nephrolithiasis. Semin Nephrol 28: 174-180.
46. Maalouf NM, Cameron MA, Moe OW, Sakhaee K (2004) Novel insights into the pathogenesis of uric acid nephrolithiasis. Curr Opin Nephrol Hypertens 13: 181-189.
47. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC (2003) Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 63: 1817-1823.
48. Grundy SM (2008) Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 28: 629-636.
49. Romero V, Akpinar H, Assimos DG (2010) Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol 12: 86-96.
50. Croppi E (2012) Ferraro PM, Taddei L, Gambaro G; GEA Firenze Study Group: prevalence of renal stones in an Italian urban population: a general practice-based study. Urol Res 40: 517-522.
51. Taylor EN, Stampfer MJ, Curhan GC (2005) Obesity, weight gain, and the risk of kidney stones. JAMA 293: 455-462.
52. Scales CD Jr, Curtis LH, Norris RD et al (2007) Changing gender prevalence of stone disease. J Urol 177: 979-982.
53. Blaak E (2001) Gender differences in fat metabolism. Curr Opin Clin Nutr Metab Care 4: 499-502.
54. Taylor EN, Curhan GC (2008) Determinants of 24-hour urinary oxalate excretion. Clin J Am Soc Nephrol 3: 1453-1460.
55. Rendina D, De Filippo G, De Pascale F et al (2013) The changing profile of patients with calcium nephrolithiasis and the ascendancy of overweight and obesity: a comparison of two patients' series observed 25 years apart. Nephrol Dial Transplant 28: iv146-151 (Suppl 4).
56. Schaeffer AJ, Feng Z, Trock BJ et al (2011) Medical comorbidities associated with pediatric kidney stone disease. Urology 77: 195-199.
57. Sakhaee K (2008) Nephrolithiasis as a systemic disorder. Curr Opin Nephrol Hypertens 17: 304-309.